ScholarLens Back to search
2016•Family MedicineOpen access

About Results of Successive Application Two «Strategies» of Antiviral Therapy of Chronic Hepatitis B Patients

Nihiar Nagiyeva, Murad Mamedov

Open full text 0 citations

Abstract

The authors presented main results of their clinical observation for 128 chronic hepatitis B (CHB), which underwent antiviral therapy with pegilated interferon for 6 months. 44,5% of these patients had sustained virological response (SVR). Then 55,5% patients who after therapy had no SVR were additionally treated with one of nucleosides analog for 18 month. Finally 6 month later after end of second therapy SVR was registered at more than 90% of CHB patients.

About this research paper

What this paper is about

The authors presented main results of their clinical observation for 128 chronic hepatitis B (CHB), which underwent antiviral therapy with pegilated interferon for 6 months. 44,5% of these patients had sustained virological response (SVR). Then 55,5% patients who after therapy had no SVR were additionally treated with one of nucleosides analog for 18 month. Finally 6 month later after end of second therapy SVR was registered at more than 90% of CHB patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The authors presented main results of their clinical observation for 128 chronic hepatitis B (CHB), which underwent antiviral therapy with pegilated interferon for 6 months. 44,5% of these patients had sustained virological response (SVR). Then 55,5% patients who after therapy had no SVR were additionally treated with one of nucleosides analog for 18 month. Finally 6 month later after end of second therapy SVR was registered at more than 90% of CHB patients.

Key concepts: Medicine, Antiviral therapy, Chronic hepatitis, Internal medicine, Gastroenterology, Interferon, Immunology, Virus

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
About Results of Successive Application Two «Strategies» of Antiviral Therapy of Chronic Hepatitis B Patients — Research Paper | ScholarLens